ArticleAnnals of gastroenterology

Impact of neutrophil-to-lymphocyte ratio on survival outcomes among cirrhotic and non-cirrhotic patients with advanced hepatocellular carcinoma under atezolizumab-bevacizumab combination therapy.

Spyridon Pantzios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.